UK Biotech Co. Abcam Expands With $170M Epitomics Buy
U.K. life sciences company Abcam PLC has agreed to spend $170 million to acquire U.S. company Epitomics International Inc., which provides antibodies to researchers, as part of a strategy to expand...To view the full article, register now.
Already a subscriber? Click here to view full article